This Soaring Stock Just Delivered More Good News. Time to Buy?
It's hard to find a biotech company that has performed better than Summit Therapeutics ( NASDAQ: SMMT ) in the past year. The stock is up by a whopping 512%, and it's no secret why.Summit, a specialist in oncology, has made excellent clinical progress with its leading candidate, ivonescimab.
Longeveron® to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025
Longeveron (LGVN) will report Q1 2025 financial results and provide a business update on Thursday, May 8, 2025 after the U.S. financial markets close.
Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT ( 14:00 CET )
Alvotech ( NASDAQ: ALVO ) , a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first quarter ended March 31, 2025, after U.S. markets close on Wednesday, May 7, ...
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results
On track for six major study readouts across four programs over the next 12 months ...
Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT
REYKJAVIK, Iceland, May 02, 2025 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) , a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first quarter ended March 31, ...
Five Below Announces Planned Board Chair Transition Following 2025 Annual Meeting And Raises Outlook for First Quarter of 2025
PHILADELPHIA, PA, May 02, 2025 ( GLOBE NEWSWIRE ) -- Five Below, Inc. ( NASDAQ: FIVE ) , the trend-right, high-quality extreme-value retailer for pre-teens and teens, announced that Tom Vellios, the Company's co-founder and Executive Chair, will transition into an advisory role to the Five Below ...
Draganfly Announces Pricing of US$3.6 Million Underwritten Public Offering
Saskatoon, SK., May 02, 2025 ( GLOBE NEWSWIRE ) -- Draganfly Inc. ( NASDAQ: DPRO ) ( CSE: DPRO ) ( FSE: 3U8A ) ( "Draganfly" or the "Company" ) , a drone solutions, and systems developer, today announced the pricing of its previously announced underwritten public offering ( the "Offering" ) of ...
VCIG's Consulting Arm, V Capital Consulting Group, Secures Nasdaq IPO Advisory Mandate with AgriTech Innovator, Saturn Agtech
V Capital Consulting Group to Lead Saturn's Nasdaq Listing, Highlighting Strong Demand for U.S. Market Access Among Southeast Asian Tech Companies V Capital Consulting Group to Lead Saturn's Nasdaq Listing, Highlighting Strong Demand for U.S. Market Access Among Southeast Asian Tech Companies ...












